3-氮杂环丁腈盐酸盐，CAS 登记号 345954-83-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-氮杂环丁腈盐酸盐 的 CAS 号：345954-83-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
azetidine-3-carbonitrile hydrochloride · CAS 345954-83-8 · C4H7ClN2.
| CAS Registry Number | 345954-83-8 |
|---|---|
| PubChem CID | 45072465 |
| Molecular formula | C4H7ClN2 |
| IUPAC name | azetidine-3-carbonitrile;hydrochloride |
| Molecular Weight | 118.56 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 118.0297759 |
| Monoisotopic Mass | 118.0297759 |
| Topological Polar Surface Area | 35.8 |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 85 |
| Reported hazard statements | H301 (92.9%), H319 (100%), H411 (92.9%) |
|---|
H301 (92.9%): Toxic if swallowed [Danger Acute toxicity, oral]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Azetidine-3-carbonitrile hydrochloride; RefChem:560527; 674-595-6; 345954-83-8; Azetidine-3-carbonitrile HCl; 3-Azetidinecarbonitrile,hydrochloride (1:1); 3-azetidinecarbonitrile hydrochloride; MFCD09749828; C4H7ClN2; azetidine-3-carbonitrile;hydrochloride; 3-CYANOAZETIDINE HYDROCHLORIDE; DTXSID00662566; PB25163; SY032760; azetidine-3-carbonitrile hydrochloride, AldrichCPR; 3-cyano-azetidine hcl salt
CAS 345954-83-8; molecular formula C4H7ClN2; molecular weight — g/mol.
Azetidine-3-carbonitrile hydrochloride, RefChem:560527, 674-595-6, 345954-83-8, Azetidine-3-carbonitrile HCl, 3-Azetidinecarbonitrile,hydrochloride (1:1).
Hazard statements reported: H301, H319, H411.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.